# Aytu Biopharma, Inc: filings

AYTU · Nasdaq · CIK 1385818 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/aytu.md) · [Financials](/companies/aytu/financials.md) · [Filings](/companies/aytu/filings.md) · [Insiders](/companies/aytu/insiders.md)

## Reports and events: 372 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 224, 4 154, 10-Q 53, 424B3 45, CORRESP 40, UPLOAD 29, EFFECT 26, 3 24, SC 13G/A 22, 425 21, SC 13G 20, 10-K 18, S-1/A 18, DEF 14A 16, DEFA14A 16, 424B5 12, S-1 12, SC 13D/A 12, 8-K/A 9, PRE 14A 9, SCHEDULE 13G/A 8, 4/A 7, D 7, FWP 7, S-3 7, 424B4 6, POS AM 6, S-8 5, SC 13D 4, SCHEDULE 13G 4, 10-K/A 3, ARS 3, CT ORDER 3, DEF 14C 3, S-1MEF 3, S-3/A 3, S-4 3, 10-Q/A 2, NT 10-K 2, NT 10-Q 2, PRE 14C 2, PRER14A 2, S-4/A 2, SC TO-I/A 2, 3/A 1, 424B2 1, 5 1, 8-A12B 1, CERTNAS 1, D/A 1, DEL AM 1, DRS 1, SCHEDULE 13D/A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:30 ET | [DEF 14A](/filings/0001437749-26-033276.md) | Proxy statement, period 2026-12-10 | 0001437749-26-033276 |
| 2026-09-22 | 16:14 ET | [10-K](/filings/0001437749-26-030908.md) | Annual report, period 2026-06-30 | 0001437749-26-030908 |
| 2026-09-22 | 16:05 ET | [8-K](/filings/0001437749-26-030900.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-030900 |
| 2026-06-25 | 16:31 ET | [8-K](/filings/0001437749-26-021707.md) | 1.02 Termination of a material agreement | 0001437749-26-021707 |
| 2026-05-13 | 16:08 ET | [10-Q](/filings/0001437749-26-016721.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016721 |
| 2026-05-13 | 16:05 ET | [8-K](/filings/0001437749-26-016717.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016717 |
| 2026-04-02 | 16:08 ET | [8-K](/filings/0001437749-26-011116.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001437749-26-011116 |
| 2026-02-03 | 16:08 ET | [10-Q](/filings/0001437749-26-002804.md) | Quarterly report, period 2025-12-31 | 0001437749-26-002804 |
| 2026-02-03 | 16:05 ET | [8-K](/filings/0001437749-26-002799.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-002799 |
| 2026-01-20 | 16:05 ET | [8-K](/filings/0001437749-26-001543.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-001543 |
| 2025-12-10 | 16:05 ET | [8-K](/filings/0001437749-25-037389.md) | 5.07 Shareholder vote results | 0001437749-25-037389 |
| 2025-11-13 | 16:11 ET | [10-Q](/filings/0001437749-25-034825.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034825 |
| 2025-11-13 | 16:08 ET | [8-K](/filings/0001437749-25-034822.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034822 |
| 2025-10-24 | 16:02 ET | [DEF 14A](/filings/0001437749-25-031719.md) | Proxy statement, period 2025-12-10 | 0001437749-25-031719 |
| 2025-09-23 | 16:06 ET | [10-K](/filings/0001437749-25-029723.md) | Annual report, period 2025-06-30 | 0001437749-25-029723 |
| 2025-09-23 | 16:05 ET | [8-K](/filings/0001437749-25-029721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-029721 |
| 2025-08-07 | 16:20 ET | [8-K](/filings/0001437749-25-025441.md) | 1.02 Termination of a material agreement | 0001437749-25-025441 |
| 2025-06-23 | 08:00 ET | [8-K](/filings/0001437749-25-020973.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-020973 |
| 2025-06-17 | 06:05 ET | [8-K](/filings/0001437749-25-020579.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-020579 |
| 2025-06-09 | 16:31 ET | [SCHEDULE 13D/A](/filings/0001104659-25-057855.md) | Ownership report, active investor, amended | 0001104659-25-057855 |
| 2025-06-09 | 16:30 ET | [8-K](/filings/0001437749-25-019868.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019868 |
| 2025-06-06 | 16:07 ET | [8-K](/filings/0001437749-25-019719.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-019719 |
| 2025-06-06 | 16:07 ET | [8-K](/filings/0001437749-25-019718.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-019718 |
| 2025-06-05 | 16:15 ET | [S-1/A](/filings/0001437749-25-019550.md) | Registration statement, amended | 0001437749-25-019550 |
| 2025-06-02 | 17:16 ET | [S-1](/filings/0001437749-25-019189.md) | Registration statement | 0001437749-25-019189 |
| 2025-05-21 | 16:20 ET | [8-K](/filings/0001437749-25-017989.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-017989 |
| 2025-05-14 | 16:07 ET | [10-Q](/filings/0001437749-25-016833.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016833 |
| 2025-05-14 | 16:06 ET | [8-K](/filings/0001437749-25-016832.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016832 |
| 2025-03-28 | 16:02 ET | [DEF 14A](/filings/0001437749-25-009836.md) | Proxy statement, period 2025-05-21 | 0001437749-25-009836 |
| 2025-02-12 | 16:12 ET | [10-Q](/filings/0001437749-25-003568.md) | Quarterly report, period 2024-12-31 | 0001437749-25-003568 |
| 2025-02-12 | 16:05 ET | [8-K](/filings/0001437749-25-003563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-003563 |
| 2024-12-04 | 21:30 ET | [8-K](/filings/0001437749-24-036630.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-036630 |
| 2024-11-13 | 17:20 ET | [10-Q](/filings/0001437749-24-034970.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034970 |
| 2024-11-13 | 16:05 ET | [8-K](/filings/0001437749-24-034898.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-034898 |
| 2024-10-01 | 08:00 ET | [8-K](/filings/0001437749-24-030297.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030297 |
| 2024-09-26 | 16:32 ET | [8-K](/filings/0001437749-24-030075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-030075 |
| 2024-09-26 | 16:05 ET | [10-K](/filings/0001437749-24-030062.md) | Annual report, period 2024-06-30 | 0001437749-24-030062 |
| 2024-08-06 | 08:00 ET | [8-K](/filings/0001437749-24-024725.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-024725 |
| 2024-06-26 | 16:36 ET | [8-K](/filings/0001437749-24-021296.md) | 5.07 Shareholder vote results | 0001437749-24-021296 |
| 2024-06-18 | 16:30 ET | [SC 13D/A](/filings/0001104659-24-072841.md) | Ownership report, active investor, amended | 0001104659-24-072841 |
| 2024-06-18 | 08:05 ET | [8-K](/filings/0001437749-24-020590.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-020590 |
| 2024-05-15 | 16:12 ET | [8-K](/filings/0001437749-24-017058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-017058 |
| 2024-05-15 | 16:11 ET | [10-Q](/filings/0001437749-24-017051.md) | Quarterly report, period 2024-03-31 | 0001437749-24-017051 |
| 2024-05-10 | 16:06 ET | [DEF 14A](/filings/0001437749-24-016003.md) | Proxy statement, period 2024-06-26 | 0001437749-24-016003 |
| 2024-02-14 | 16:12 ET | [8-K](/filings/0001437749-24-004155.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-004155 |
| 2024-02-14 | 16:05 ET | [10-Q](/filings/0001437749-24-004149.md) | Quarterly report, period 2023-12-31 | 0001437749-24-004149 |
| 2023-11-17 | 16:10 ET | [8-K](/filings/0001558370-23-019194.md) | 1.01 Entry into a material agreement | 0001558370-23-019194 |
| 2023-11-14 | 16:10 ET | [8-K](/filings/0001558370-23-019023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-019023 |
| 2023-11-14 | 16:05 ET | [10-Q](/filings/0001558370-23-019015.md) | Quarterly report, period 2023-09-30 | 0001558370-23-019015 |
| 2023-10-26 | 08:05 ET | [8-K](/filings/0001558370-23-016776.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-016776 |

Page 1 of 8. [Older](/companies/aytu/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:32 ET. No prices; not investment advice.